Lina Benson

TL;DR: Women with atrial fibrillation have a moderately increased risk of stroke compared with men, and thus, female sex should be considered when making decisions about anticoagulation treatment, but women younger than 65 years and without other risk factors have a low risk for stroke, and do not need antICOagulant treatment.

TL;DR: Clinical features and outcomes in the novel phenotype heart failure with mid‐range ejection fraction with reduced EF and preserved EF were compared with heart failure With reduced EF (HFrEF, EF <40%) and preservedEF (HFp EF, EF ≥50%).

TL;DR: HFmrEF resembled HFrEF rather than HFpEF with regard to both a higher prevalence of IHD and a greater risk of new IHD events, and established IHD was an important prognostic factor across all HF types.

TL;DR: Among patients with heart failure and preserved ejection fraction, the use of RAS antagonists was associated with lower all-cause mortality.

TL;DR: Patients with both atrial fibrillation and renal failure will probably benefit most from having the same treatment as is recommended for other patients with AF, without setting a higher or lower threshold for treatment.